Closing Remarks

Co-Chair(s)

• 

  Francis RW Godwin, MBA

  Office Director, OC, CDER
  U.S. FDA
  Silver Spring, Maryland, United States
• 

  Valerie Whelan

  Vice President, Quality
  Thermo Fisher Scientific
  Ballycoolin, Dublin, Ireland